Division of Compensation Analysis and

Support

Program Evaluation Report

Document Number: DCAS-PER-075

Effective Date: 12/08/2017

Revision No. 0

Battelle Memorial Institute TBD Revision Page 1 of 2

Author: Signature on file Date: 12/08/2017 

 Dave Allen, HP Team Leader

Approval: Signature on file Date: 12/08/2017 

 J. W. Neton, Associate Director for Science

Supersedes: none

RECORD OF ISSUE/REVISIONS

ISSUE 

AUTHORIZATION 

DATE

EFFECTIVE

DATE

REV. NO. DESCRIPTION

12/08/2017 12/08/2017 0 New document to determine the effect of 

revision 1 to ORAUT-OTIB-0058

(Battelle Memorial Institute) on 

previously completed claims.

1.0 Description

On 3/26/2010, ORAUT-TKBS-0058, the Site Profile for Battelle Memorial Institute King 

Avenue and West Jefferson Sites (BMI) was issued. A class of Kings Avenue employees 

were designated as members of the Special Exposure Cohort (SEC) on 3/6/2013 with an 

additional class designated on 2/18/2016. As a result of the SEC review, on 6/27/2016 

revision 1 of ORAUT-TKBS-0058 was issued. This PER is being prepared to consider 

the effect of the revision to ORAUT-TKBS-0058 on previously completed claims.

2.0 Issue Evaluation

Revision 1 of the site profile included the following changes:

 Environmental internal and external doses were included in this revision

 Recycled uranium components were added

 Readers are now directed to ORAUT-OTIB-0076 for assessing thorium 

intakes

 Multiplication factors were included to assess beta dose expressed in arbitrary 

units (a.u.) in dose records.
Division of Compensation Analysis and 

Support

Program Evaluation Report

Document Number: DCAS-PER-075

Effective Date: 12/08/2017 Revision No.: 0 Page 2 of 2

These changes have a potential to affect any previously completed claim so all previously 

claims from BMI must be considered. Because there is potential that some claims may

not have been affected by any of these changes, part of the evaluation will include a caseby-case review to determine if any of the changes affect a particular claim.

3.0 Plan for Resolving Corrective Action

To establish the population of claims potentially affected, a search of the NOCTS 

database was conducted for those claims with BMI employment (both the Kings Avenue 

and West Jefferson sites). This search discovered a total of 91 claims. Twenty seven of 

these claims resulted in a probability of causation (POC) greater than 50% and were 

removed from further evaluation. An additional 20 claims were either completed using 

revision 1 of the site profile, were awaiting a dose reconstruction at NIOSH at the time of 

the search (and would then be completed using revision 1) or they were pulled from dose 

reconstruction (meaning DOL no longer needed a dose reconstruction to determine 

whether the claim was compensable). These 20 claims were also removed from further 

evaluation leaving 44 claims to evaluate. 

An additional search for the word “Battelle” was conducted on dose reconstruction 

reports. This search produced 3126 claims. Seventy two of these were duplicates of the 

claims described above. Additionally, 3050 claims contained the word Battelle but had 

no visits or other connection to the BMI. Most of these were the result of referencing 

Battelle-TBD-6000 or similar documents. The remaining 4 claims from the second 

search were added to the initial search producing a population of 48 claims. Lastly, these 

claims were reviewed to determine is they qualified for inclusion in the BMI or other 

SEC. Twelve of these claims were members of an SEC and were removed from further 

evaluation. This left 36 claims to be evaluated further.

The 36 claims were evaluated to determine if any of the changes to the site profile

affected the calculated dose. In a case-by-case review, it was determined that all but 5 of 

the claims were unaffected by the changes made to the site profile. For those 5, the dose 

was recalculated using revision 1 of the site profile as well as the current revision of any 

other applicable documents. Four of the claim resulted in a POC less than 45%. The 

remaining claim resulted in a POC between 45 and 50%. For this claim, IREP was run 

30 times at 10,000 iterations per NIOSH procedures. The resulting POC was less than 

50%. 

NIOSH will provide the Department of Labor with the list of all the claims evaluated 

under this PER. Since none of the re-evaluated doses resulted in a POC greater than 

50%, NIOSH will not request the return of any claims.